AIGEN INVESTMENT MANAGEMENT, LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2023$545,732
-18.7%
8,635
-35.0%
0.08%
-28.3%
Q2 2022$671,000
+17.7%
13,284
+48.9%
0.11%
+15.3%
Q1 2022$570,000
-54.7%
8,920
-37.7%
0.10%
-55.5%
Q2 2021$1,259,000
+373.3%
14,314
+214.7%
0.22%
+528.6%
Q1 2020$266,000
+786.7%
4,549
+1122.8%
0.04%
+600.0%
Q4 2019$30,0003720.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders